3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide

C150H147N47O18S — CID 167629987

IUPAC3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide
SMILESCC(C)(C)c1noc(CCC(=O)Nc2n[nH]c(-c3ccccn3)n2)n1.CN(CC(=O)CC1=NN=C(c2ccccn2)C1)S(C)(=O)=O.Cc1noc(C)c1CC(=O)Nc1n[nH]c(-c2ccccn2)n1.N#Cc1ccccc1OCC(=O)CC1=NN=C(c2ccccn2)C1.O=C(CC1=NN=C(c2ccccn2)C1)C1COc2ccccc2C1.O=C(Cc1ccccc1)NCCC(=O)Nc1n[nH]c(-c2ccccn2)n1.O=C(Nc1n[nH]c(-c2ccccn2)n1)C1CC(=O)N(CCc2ccccc2)C1.O=C(Nc1n[nH]c(-c2ccccn2)n1)C1CCCC1.O=C(Nc1n[nH]c(-c2ccccn2)n1)c1ccc(Oc2ccccc2)nc1
InChIInChI=1S/C20H20N6O2.C19H14N6O2.C19H17N3O2.C18H18N6O2.C18H14N4O2.C16H19N7O2.C14H14N6O2.C13H15N5O.C13H16N4O3S/c27-17-12-15(13-26(17)11-9-14-6-2-1-3-7-14)19(28)23-20-22-18(24-25-20)16-8-4-5-10-21-16;26-18(23-19-22-17(24-25-19)15-8-4-5-11-20-15)13-9-10-16(21-12-13)27-14-6-2-1-3-7-14;23-18(14-9-13-5-1-2-7-19(13)24-12-14)11-15-10-17(22-21-15)16-6-3-4-8-20-16;25-15(9-11-20-16(26)12-13-6-2-1-3-7-13)21-18-22-17(23-24-18)14-8-4-5-10-19-14;19-11-13-5-1-2-7-18(13)24-12-15(23)9-14-10-17(22-21-14)16-6-3-4-8-20-16;1-16(2,3)14-19-12(25-23-14)8-7-11(24)18-15-20-13(21-22-15)10-6-4-5-9-17-10;1-8-10(9(2)22-20-8)7-12(21)16-14-17-13(18-19-14)11-5-3-4-6-15-11;19-12(9-5-1-2-6-9)16-13-15-11(17-18-13)10-7-3-4-8-14-10;1-17(21(2,19)20)9-11(18)7-10-8-13(16-15-10)12-5-3-4-6-14-12/h1-8,10,15H,9,11-13H2,(H2,22,23,24,25,28);1-12H,(H2,22,23,24,25,26);1-8,14H,9-12H2;1-8,10H,9,11-12H2,(H,20,26)(H2,21,22,23,24,25);1-8H,9-10,12H2;4-6,9H,7-8H2,1-3H3,(H2,18,20,21,22,24);3-6H,7H2,1-2H3,(H2,16,17,18,19,21);3-4,7-9H,1-2,5-6H2,(H2,15,16,17,18,19);3-6H,7-9H2,1-2H3
InChIKeyNQONJIQCVNFXNY-UHFFFAOYSA-N
MW2928.20 g/mol
LogP18.39
Rot. Bonds46

About 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide

3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide (PubChem CID 167629987) has the molecular formula C150H147N47O18S and a molecular weight of 2928.20 g/mol. Its IUPAC name is 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide.

Molecular Properties

Compound Name3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide
PubChem CID167629987
Molecular FormulaC150H147N47O18S
Molecular Weight2928.20 g/mol
Exact Mass2926.18
IUPAC Name3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide
SMILESCC(C)(C)c1noc(CCC(=O)Nc2n[nH]c(-c3ccccn3)n2)n1.CN(CC(=O)CC1=NN=C(c2ccccn2)C1)S(C)(=O)=O.Cc1noc(C)c1CC(=O)Nc1n[nH]c(-c2ccccn2)n1.N#Cc1ccccc1OCC(=O)CC1=NN=C(c2ccccn2)C1.O=C(CC1=NN=C(c2ccccn2)C1)C1COc2ccccc2C1.O=C(Cc1ccccc1)NCCC(=O)Nc1n[nH]c(-c2ccccn2)n1.O=C(Nc1n[nH]c(-c2ccccn2)n1)C1CC(=O)N(CCc2ccccc2)C1.O=C(Nc1n[nH]c(-c2ccccn2)n1)C1CCCC1.O=C(Nc1n[nH]c(-c2ccccn2)n1)c1ccc(Oc2ccccc2)nc1
InChIInChI=1S/C20H20N6O2.C19H14N6O2.C19H17N3O2.C18H18N6O2.C18H14N4O2.C16H19N7O2.C14H14N6O2.C13H15N5O.C13H16N4O3S/c27-17-12-15(13-26(17)11-9-14-6-2-1-3-7-14)19(28)23-20-22-18(24-25-20)16-8-4-5-10-21-16;26-18(23-19-22-17(24-25-19)15-8-4-5-11-20-15)13-9-10-16(21-12-13)27-14-6-2-1-3-7-14;23-18(14-9-13-5-1-2-7-19(13)24-12-14)11-15-10-17(22-21-15)16-6-3-4-8-20-16;25-15(9-11-20-16(26)12-13-6-2-1-3-7-13)21-18-22-17(23-24-18)14-8-4-5-10-19-14;19-11-13-5-1-2-7-18(13)24-12-15(23)9-14-10-17(22-21-14)16-6-3-4-8-20-16;1-16(2,3)14-19-12(25-23-14)8-7-11(24)18-15-20-13(21-22-15)10-6-4-5-9-17-10;1-8-10(9(2)22-20-8)7-12(21)16-14-17-13(18-19-14)11-5-3-4-6-15-11;19-12(9-5-1-2-6-9)16-13-15-11(17-18-13)10-7-3-4-8-14-10;1-17(21(2,19)20)9-11(18)7-10-8-13(16-15-10)12-5-3-4-6-14-12/h1-8,10,15H,9,11-13H2,(H2,22,23,24,25,28);1-12H,(H2,22,23,24,25,26);1-8,14H,9-12H2;1-8,10H,9,11-12H2,(H,20,26)(H2,21,22,23,24,25);1-8H,9-10,12H2;4-6,9H,7-8H2,1-3H3,(H2,18,20,21,22,24);3-6H,7H2,1-2H3,(H2,16,17,18,19,21);3-4,7-9H,1-2,5-6H2,(H2,15,16,17,18,19);3-6H,7-9H2,1-2H3
InChIKeyNQONJIQCVNFXNY-UHFFFAOYSA-N
XLogP18.39
TPSA881.51 Ų
H-Bond Donors13
H-Bond Acceptors50
Rotatable Bonds46
Heavy Atoms216
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002928.20
LogP ≤ 518.39
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1050

Analyze 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide?
The IUPAC name of 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide (CID 167629987) is 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide.
What is the SMILES notation for 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide?
The canonical SMILES for 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide is CC(C)(C)c1noc(CCC(=O)Nc2n[nH]c(-c3ccccn3)n2)n1.CN(CC(=O)CC1=NN=C(c2ccccn2)C1)S(C)(=O)=O.Cc1noc(C)c1CC(=O)Nc1n[nH]c(-c2ccccn2)n1.N#Cc1ccccc1OCC(=O)CC1=NN=C(c2ccccn2)C1.O=C(CC1=NN=C(c2ccccn2)C1)C1COc2ccccc2C1.O=C(Cc1ccccc1)NCCC(=O)Nc1n[nH]c(-c2ccccn2)n1.O=C(Nc1n[nH]c(-c2ccccn2)n1)C1CC(=O)N(CCc2ccccc2)C1.O=C(Nc1n[nH]c(-c2ccccn2)n1)C1CCCC1.O=C(Nc1n[nH]c(-c2ccccn2)n1)c1ccc(Oc2ccccc2)nc1.
What is the InChIKey of 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide?
The InChIKey is NQONJIQCVNFXNY-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H20N6O2.C19H14N6O2.C19H17N3O2.C18H18N6O2.C18H14N4O2.C16H19N7O2.C14H14N6O2.C13H15N5O.C13H16N4O3S/c27-17-12-15(13-26(17)11-9-14-6-2-1-3-7-14)19(28)23-20-22-18(24-25-20)16-8-4-5-10-21-16;26-18(23-19-22-17(24-25-19)15-8-4-5-11-20-15)13-9-10-16(21-12-13)27-14-6-2-1-3-7-14;23-18(14-9-13-5-1-2-7-19(13)24-12-14)11-15-10-17(22-21-15)16-6-3-4-8-20-16;25-15(9-11-20-16(26)12-13-6-2-1-3-7-13)21-18-22-17(23-24-18)14-8-4-5-10-19-14;19-11-13-5-1-2-7-18(13)24-12-15(23)9-14-10-17(22-21-14)16-6-3-4-8-20-16;1-16(2,3)14-19-12(25-23-14)8-7-11(24)18-15-20-13(21-22-15)10-6-4-5-9-17-10;1-8-10(9(2)22-20-8)7-12(21)16-14-17-13(18-19-14)11-5-3-4-6-15-11;19-12(9-5-1-2-6-9)16-13-15-11(17-18-13)10-7-3-4-8-14-10;1-17(21(2,19)20)9-11(18)7-10-8-13(16-15-10)12-5-3-4-6-14-12/h1-8,10,15H,9,11-13H2,(H2,22,23,24,25,28);1-12H,(H2,22,23,24,25,26);1-8,14H,9-12H2;1-8,10H,9,11-12H2,(H,20,26)(H2,21,22,23,24,25);1-8H,9-10,12H2;4-6,9H,7-8H2,1-3H3,(H2,18,20,21,22,24);3-6H,7H2,1-2H3,(H2,16,17,18,19,21);3-4,7-9H,1-2,5-6H2,(H2,15,16,17,18,19);3-6H,7-9H2,1-2H3.
What are the key properties of 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide?
3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide has a molecular weight of 2928.20 g/mol, XLogP of 18.39, 46 rotatable bonds, 13 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;1-(3,4-dihydro-2H-chromen-3-yl)-2-(5-pyridin-2-yl-4H-pyrazol-3-yl)ethanone;2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)acetamide;N-methyl-N-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propyl]methanesulfonamide;5-oxo-1-(2-phenylethyl)-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyrrolidine-3-carboxamide;2-[2-oxo-3-(5-pyridin-2-yl-4H-pyrazol-3-yl)propoxy]benzonitrile;6-phenoxy-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)pyridine-3-carboxamide;3-[(2-phenylacetyl)amino]-N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)propanamide;N-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)cyclopentanecarboxamide is sourced from PubChem (CID 167629987), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).